Joseph Oliveto
Vorstandsvorsitzender bei MILESTONE PHARMACEUTICALS INC.
Vermögen: 449 730 $ am 30.04.2024
Aktive Positionen von Joseph Oliveto
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MILESTONE PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 01.07.2017 | - |
Vorstandsvorsitzender | 07.03.2017 | - | |
Präsident | 07.03.2017 | - | |
Milestone Pharmaceuticals USA, Inc.
Milestone Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Milestone Pharmaceuticals, Inc., Milestone Pharmaceuticals USA, Inc. develops cardiovascular drugs. The company is based in Charlotte, NC. Joseph G. Oliveto has been the CEO of the company since 2017. | Vorstandsvorsitzender | 07.03.2017 | - |
Präsident | 07.03.2017 | - |
Karriereverlauf von Joseph Oliveto
Ehemalige bekannte Positionen von Joseph Oliveto
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Galleon Pharmaceuticals, Inc.
Galleon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galleon Pharmaceuticals, Inc. develops and manufactures medicines for breathing-control conditions. Its product pipeline addresses the needs of both acute and chronic care patients. The firm's GAL-021 product is a small molecule for intravenous administration designed to support respiratory drive in surgical and critical care patients, and in particular those high risk patients with sleep apnea who are undergoing surgery. The company was founded by James C. Mannion in 2003 and is headquartered in Horsham, PA. | Direktor/Vorstandsmitglied | 01.07.2015 | 01.06.2016 |
Vorstandsvorsitzender | 01.07.2015 | 01.06.2016 | |
CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Direktor/Vorstandsmitglied | 13.06.2008 | 23.06.2014 |
Vorstandsvorsitzender | 11.07.2012 | 23.06.2014 | |
Geschäftsführer | 13.06.2008 | 03.02.2014 | |
Präsident | 13.06.2008 | 11.07.2012 | |
Pappas Capital LLC
Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Corporate Officer/Principal | 01.01.2006 | 30.06.2008 |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01.01.2003 | 01.01.2008 |
Ausbildung von Joseph Oliveto
Rutgers State University of New Jersey | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 6 |
Kanada | 2 |
Frankreich | 2 |
Operativ
Chief Executive Officer | 4 |
Director/Board Member | 3 |
President | 3 |
Sektoral
Health Technology | 6 |
Finance | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MILESTONE PHARMACEUTICALS INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Chelsea Therapeutics International Ltd.
Chelsea Therapeutics International Ltd. BiotechnologyHealth Technology Chelsea Therapeutics International Ltd. acquires, develops and commercializes innovative products for the treatment of a variety of human diseases. The company was founded by Simon C. Pedder on June 17, 2005 and is headquartered in Charlotte, NC. | Health Technology |
Galleon Pharmaceuticals, Inc.
Galleon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galleon Pharmaceuticals, Inc. develops and manufactures medicines for breathing-control conditions. Its product pipeline addresses the needs of both acute and chronic care patients. The firm's GAL-021 product is a small molecule for intravenous administration designed to support respiratory drive in surgical and critical care patients, and in particular those high risk patients with sleep apnea who are undergoing surgery. The company was founded by James C. Mannion in 2003 and is headquartered in Horsham, PA. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Pappas Capital LLC
Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Finance |
Milestone Pharmaceuticals USA, Inc.
Milestone Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Milestone Pharmaceuticals, Inc., Milestone Pharmaceuticals USA, Inc. develops cardiovascular drugs. The company is based in Charlotte, NC. Joseph G. Oliveto has been the CEO of the company since 2017. | Health Technology |
- Börse
- Insiders
- Joseph Oliveto
- Erfahrung